| 12351581 |
Compounds for FGFR inhibition |
Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Jennifer Fulton +9 more |
2025-07-08 |
|
| 12281122 |
PI3K inhibitors |
Payal Chatterjee, Mark Joseph Chicarelli, Michael L. Conner, John P. Fischer, Jennifer Fulton +14 more |
2025-04-22 |
|
| 12187721 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed +6 more |
2025-01-07 |
|
| 11964989 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more |
2024-04-23 |
|
| 11884664 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed +7 more |
2024-01-30 |
|
| 11634417 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed +7 more |
2023-04-25 |
|
| 11453683 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more |
2022-09-27 |
|
| 10689377 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Adam Cook +7 more |
2020-06-23 |
|
| 10669269 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2020-06-02 |
|
| 10633381 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2020-04-28 |
|
| 10125134 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2018-11-13 |
|
| 9809590 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2017-11-07 |
$14,586,000 |
| 9174981 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2015-11-03 |
$10,851,000 |
| 8865726 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Lisa A. De Meese, Jay Bradford Fell, John P. Fischer +7 more |
2014-10-21 |
$2,720,000 |
| 8841455 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors |
Mark Laurence Boys, Michael Bradley, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy +7 more |
2014-09-23 |
$3,108,000 |
| 8809538 |
Piperidine-containing compounds and use thereof |
David A. Mareska, Jeremy Hans, Darren Harvey, Robert D. Groneberg, Michael O'Sullivan |
2014-08-19 |
$6,036,000 |
| 8518983 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi +5 more |
2013-08-27 |
$8,446,000 |
| 8044083 |
Kinase inhibitors and methods of use thereof |
Robert D. Groneberg, Laurence E. Burgess, Darren Harvey, Ellen Laird, Mark Munson +3 more |
2011-10-25 |
$1,398,000 |
| 8039639 |
Kinase inhibitors and methods of use thereof |
Robert D. Groneberg, Laurence E. Burges, Darren Harvey, Ellen Laird, Mark Munson +3 more |
2011-10-18 |
$647,000 |
| 8017641 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi +5 more |
2011-09-13 |
$1,002,000 |
| 7799782 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi +5 more |
2010-09-21 |
$2,697,000 |
| 7521447 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Groneberg, James P. Rizzi +5 more |
2009-04-21 |
$2,205,000 |
| 7135575 |
P38 inhibitors and methods of use thereof |
Mark Munson, James P. Rizzi, Ganghyeok Kim |
2006-11-14 |
$4,715,000 |
| 6911443 |
Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
Takeshi Yura, Arnel Concepcion, Gyoonhee Han, Makiko Marumo, Hiroko Yoshino +13 more |
2005-06-28 |
$846,000 |
| 6586467 |
Preparation of phosphatase inhibitors |
Laurence E. Burgess, John Gaudino, Robert D. Groneberg, Mark H. Norman, Xicheng Sun +1 more |
2003-07-01 |
$1,802,000 |